Financhill
Buy
82

HIMS Quote, Financials, Valuation and Earnings

Last price:
$59.23
Seasonality move :
-1.99%
Day range:
$55.77 - $61.67
52-week range:
$13.47 - $72.98
Dividend yield:
0%
P/E ratio:
86.64x
P/S ratio:
8.08x
P/B ratio:
24.36x
Volume:
42.2M
Avg. volume:
50.8M
1-year change:
151.71%
Market cap:
$13.4B
Revenue:
$1.5B
EPS (TTM):
$0.69

HIMS Analysts' Consensus Rating

The 11 analysts providing 12-month price projections for Hims & Hers Health shares anticipate an average target of $49.80, ranging from a low estimate of $28.00 to a high estimate of $85.00. This average target implies a growth of -16.7% compared to the current stock price of $59.78.

Consensus Price Target

$49.80

Highest Price Target

$85.00

Lowest Price Target

$28.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 4 4

Hold 7 6 6

Sell 0 1 1
Consensus Hold Hold Hold

HIMS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.

Buy
75
ARQQ alert for Jun 17

Arqit Quantum [ARQQ] is up 6.36% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 3.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock